Commence people with average hepatic impairment on 25% in the hydromorphone hydrochloride prolonged-release tablets dose that will be prescribed for sufferers with ordinary hepatic function. Carefully monitor people with moderate hepatic impairment for respiratory and central nervous procedure depression through initiation of therapy with hydromorp… Read More